MedTrace Logo

Impacts of the Positive Youth Development Program for Expectant and Parenting Teens in California

NCT04181034 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1330

Last updated 2021-02-25

No results posted yet for this study

Summary

Under contract to the U.S. Department of Health and Human Services (DHHS), Mathematica is conducting an impact study of California Department of Public Health, Center for Family Health, Maternal, Child and Adolescent Health's (MCAH) Adolescent Family Life Program Positive Youth Development (PYD) program for a Federal Evaluation of Programs for Expectant and Parenting Youth (PEPY). The impact study will be designed to address the impact of PYD, compared to the business-as-usual condition, AFLP, in delaying repeat pregnancies, completing high school, improving health of the parent and child, and improving linkages and networks of support for expectant and parenting teens.

Conditions

  • Teen Pregnancy Prevention

Interventions

BEHAVIORAL

Adolescent Family Life Program Positive Youth Development (PYD) program

Home visiting program for pregnant and parenting teens with PYD component

BEHAVIORAL

Adolescent Family Life Program (AFLP)

Home visiting program for pregnant and parenting teens

Sponsors & Collaborators

  • Office of Population Affairs

    collaborator UNKNOWN

  • California Department of Public Health, MCAH

    collaborator UNKNOWN

  • Mathematica Policy Research, Inc.

    lead OTHER

Principal Investigators

  • Susan Zief, PhD · Mathematica Policy Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-03
Primary Completion
2018-05-25
Completion
2018-05-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04181034 on ClinicalTrials.gov